Prenetics Halts Bitcoin Purchases, Pivots Aggressively to IM8 Wellness Brand

Prenetics just pulled the plug on its Bitcoin treasury strategy. The genomics and diagnostics firm is making a sharp turn, redirecting all that speculative energy into its newly launched IM8 consumer wellness brand. It's a classic pivot—out with the digital gold, in with the gut health supplements.

From Crypto Speculation to Supplement Sales

The move signals a dramatic shift in corporate priorities. Instead of chasing volatility on the balance sheet, Prenetics is betting on recurring revenue from health-conscious consumers. The IM8 brand, promising longevity and metabolic health, is now the undisputed center of the growth universe. Management's message is clear: the future is in pills and powders, not private keys.

The Wellness Pivot Playbook

This isn't just a product launch—it's a full-scale strategic realignment. Every resource, every marketing dollar, and every ounce of executive attention is being funneled into making IM8 a household name in preventative health. They're bypassing the noisy crypto narrative altogether, aiming for the supposedly steadier, more predictable world of direct-to-consumer wellness. It's a calculated bet that daily vitamins have more reliable margins than Satoshi's invention.

So, Prenetics joins the growing list of companies that flirted with Bitcoin as a corporate asset, only to retreat when the going got tough—or when a shinier, more tangible opportunity appeared. One can't help but wonder if this is visionary foresight or just another case of corporate attention deficit disorder, chasing the next hot trend while the finance team quietly writes off the last one.

TLDR

• Prenetics halts daily Bitcoin purchases as of Dec. 4, focusing on IM8 growth.
• IM8 surpassed $100 million in annualized recurring revenue in just 11 months.
• Prenetics has $70 million in cash and no debt to fund IM8’s expansion.
• The company will keep its 510 Bitcoin holdings but will no longer acquire more.

Prenetics Global Limited, a health sciences company listed on Nasdaq, announced a significant shift in its investment strategy. On December 4th, the company ended its daily Bitcoin purchasing program, redirecting all its focus and capital toward the rapid growth of IM8, its consumer health and longevity brand. This move follows the approval of its board and marks a strategic pivot from cryptocurrency investments to expanding the IM8 brand.

Prenetics, a health-sciences firm that began investing in Bitcoin earlier this year, has halted that strategy due to falling crypto prices. The firm said it stopped buying Bitcoin on Dec. 4 and will focus more on IM8, a nutritional supplement brand co-founded by football icon… pic.twitter.com/GIdokX9Bq4

— crypto Crib (@Crypto_Crib_) December 30, 2025

IM8, co-founded by Prenetics and global sports icon David Beckham, has seen remarkable success, surpassing $100 million in annualized recurring revenue just 11 months after its launch. Prenetics’ decision to pause bitcoin purchases reflects the company’s new commitment to scaling IM8, with the goal of sustaining long-term shareholder value.

Prenetics Shifts Focus to IM8’s Growth

Prenetics emphasized that its focus will now solely be on the development of IM8, a growing health and wellness brand that markets a daily all-in-one nutritional supplement. Since its launch, IM8 has rapidly scaled its operations, and the company projects that its revenue for fiscal year 2026 will range between $180 million and $200 million.

Danny Yeung, CEO of Prenetics, commented on the decision, stating that the shift was made to align resources with the most promising growth opportunity. “The phenomenal success of IM8 has exceeded all expectations, and concentrating our efforts here provides the clearest path for long-term shareholder value,” Yeung explained.

IM8 HEALTH CEASES BITCOIN TREASURY STRATEGY TO FOCUS EXCLUSIVELY ON Core SUPPLEMENT BRAND

IM8 Health this morning announced that it WOULD cease accumulating bitcoin for its treasury strategy.

In my breakdown on the company (NASDAQ: $PRE) I said this was a bit of a distraction.… pic.twitter.com/woI2WV4Opq

— Drew Fallon (@drewfallon12) December 30, 2025

With the company’s strong financial position, including over $70 million in cash and no debt, Prenetics is poised to continue its investment in IM8’s product development, marketing strategies, and international expansion.

Bitcoin Holdings Remain Part of Treasury Reserve

While Prenetics has stopped acquiring Bitcoin, the company clarified that its existing 510 Bitcoin holdings will remain intact as part of its treasury reserve. However, the company will not be allocating any further capital to expand this position. This MOVE signals a departure from the strategy Prenetics embraced earlier, during the Bitcoin market’s rise, where companies started holding cryptocurrencies as treasury assets.

At the time of this decision, Bitcoin was trading at approximately $88,626, reflecting a 1% increase over the past 24 hours. Prenetics’ Bitcoin holdings remain valuable but will no longer be a central part of the company’s capital deployment strategy. Instead, the company will focus entirely on IM8’s potential to disrupt the consumer health market.

The Shift Away from Cryptocurrency Amid Market Challenges

Prenetics’ decision also comes at a time when the cryptocurrency market faces a downturn. Bitcoin and other digital assets have struggled to regain momentum after a significant price drop earlier in the year. As the market sentiment weakens, many companies that once focused on cryptocurrency-heavy strategies are shifting their priorities back to their core businesses.

Prenetics’ move to concentrate on IM8 reflects this broader trend, where companies are reassessing their involvement in volatile markets like cryptocurrency. Despite this shift, Prenetics maintains a strong financial outlook and remains committed to its CORE health and wellness mission with IM8.

The company’s leadership sees IM8 as a clear avenue for long-term success and shareholder value, with its continued focus on leveraging celebrity partnerships and strong consumer demand.